<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title9.html">
                                    Title 9
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/9CFR121.html">Part 121
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 121.6  Exemptions for overlap select agents and toxins.
                            </h3>
                            <p class="depth1"><em>(a)</em> Clinical or diagnostic laboratories and other entities that  possess, use, or transfer an overlap select agent or toxin that is  contained in a specimen presented for diagnosis or verification will be  exempt from the requirements of this part for such agent or toxin  contained in the specimen, provided that:</p><p class="depth2"><em>(1)</em> Unless directed otherwise by the Administrator or the HHS  Secretary, within 7 calendar days after identification, the agent or  toxin is transferred in accordance with Sec. 121.16 or 42 CFR 73.16 or  destroyed on-site by a recognized sterilization or inactivation process;</p><p class="depth2"><em>(2)</em> The agent or toxin is secured against theft, loss, or release  during the period between identification of the agent or toxin and  transfer or destruction of such agent or toxin, and any theft, loss, or  release of such agent or toxin is reported; and</p><p class="depth2"><em>(3)</em> The identification of the agent or toxin is reported to APHIS or  CDC.</p><p class="depth3"><em>(i)</em> The identification of any of the following overlap select agents  and toxins must be immediately reported by telephone, facsimile, or e- mail: Bacillus anthracis, Burkholderia mallei, or Burkholderia  pseudomallei. This report must be followed by submission of APHIS/CDC  Form 4 within 7 calendar days after identification.</p><p class="depth3"><em>(ii)</em> For all other overlap select agents or toxins, APHIS/CDC Form 4  must be submitted within 7 calendar days after identification.</p><p class="depth3"><em>(iii)</em> Less stringent reporting may be required during agricultural  emergencies or outbreaks, or in endemic areas.</p><p class="depth3"><em>(iv)</em> A copy of APHIS/CDC Form 4 must be maintained for 3 years.</p><p class="depth1"><em>(b)</em> Clinical or diagnostic laboratories and other entities that  possess, use, or transfer an overlap select agent or toxin that is  contained in a specimen presented for proficiency testing will be exempt  from the requirements of this part for such agent or toxin contained in  the specimen, provided that:</p><p class="depth2"><em>(1)</em> Unless directed otherwise by the Administrator or the HHS  Secretary, within 90 days of receipt, the agent or toxin is transferred  in accordance with Sec. 121.16 or 42 CFR 73.16 or destroyed on-site by  a recognized sterilization or inactivation process;</p><p class="depth2"><em>(2)</em> The agent or toxin is secured against theft, loss, or release  during the period between identification of the agent or toxin and  transfer or destruction of such agent or toxin, and any theft, loss, or  release of such agent or toxin is reported; and</p><p class="depth2"><em>(3)</em> The identification of the agent or toxin, and its derivative, is  reported to APHIS or CDC. To report the identification of an overlap  select agent or toxin, APHIS/CDC Form 4 must be submitted within 90  calendar days of receipt of the agent or toxin. A copy of the completed  form must be maintained for 3 years.</p><p class="depth1"><em>(c)</em> Unless the Administrator by order determines that additional  regulation of a specific product is necessary to protect animal health  or animal products, products that are, bear, or contain overlap select  agents or toxins will be exempt from the requirements of this part if  the products have been cleared, approved, licensed, or registered  pursuant to:</p><p class="depth2"><em>(1)</em> The Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et  seq.);</p><p class="depth2"><em>(2)</em> Section 351 of Public Health Service Act (42 U.S.C. 262);</p><p class="depth2"><em>(3)</em> The Virus-Serum-Toxin Act (21 U.S.C. 151-159); or</p><p class="depth2"><em>(4)</em> The Federal Insecticide, Fungicide, and Rodenticide Act (7  U.S.C. 131 et seq.).</p><p class="depth1"><em>(d)</em> After consultation with the HHS Secretary, the Administrator may  exempt from the requirements of this part an investigational product  that is, bears, or contains an overlap select agent or toxin if such  product is being used in an investigation authorized by any Federal law  and the Administrator determines that additional regulation under this  part is not necessary to protect animal health or animal products.</p><p class="depth2"><em>(1)</em> To apply for an exemption, an individual or entity must submit  APHIS/CDC Form 5.</p><p class="depth2"><em>(2)</em> The Administrator will make a determination regarding an  exemption within 14 calendar days after receipt of the application and  notification that the investigation has been authorized under a Federal  law. A written decision granting or denying the exemption will be  issued.</p><p class="depth2"><em>(3)</em> The applicant must notify APHIS or CDC when an authorization for  an investigation no longer exists. This exemption automatically  terminates when such authorization is no longer in effect.</p><p class="depth1"><em>(e)</em> If it is necessary to respond to a domestic or foreign  agricultural emergency involving an overlap select agent or toxin, the  Administrator may exempt an individual or entity from the requirements,  in whole or in part, of this part for up to 30 calendar days. The  Administrator may extend the exemption once for an additional 30 days.</p><p class="depth1"><em>(f)</em> Upon request of the Secretary of Health and Human Services, the  Administrator may exempt an individual   or entity from the requirements, in whole or in part, of this part for  up to 30 calendar days if the Secretary of Health and Human Services has  granted an exemption for a public health emergency involving an overlap  select agent or toxin. The Administrator may extend the exemption once  for an additional 30 days.  [70 FR 13284, Mar. 18, 2005, as amended at 73 FR 61331, Oct. 16, 2008;  77 FR 61078, Oct. 5, 2012; 79 FR 26831, May 12, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
